Jennifer Schnippert
Family · Tallahassee, FLNPI 1801204987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations.
Across 77 payments — averaging $44.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$452
- Novo Nordisk$388
- AbbVie$258
- Lilly USA, LLC$234
- Bayer$170
- Eisai Inc.$123
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $452 |
| Novo Nordisk | 5 | $388 |
| AbbVie | 5 | $258 |
| Lilly USA, LLC | 7 | $234 |
| Bayer | 2 | $170 |
| Eisai Inc. | 1 | $123 |
| MDD US Operations, LLC | 1 | $118 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Abbott | 3 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $112 |
| Acadia Pharmaceuticals Inc | 2 | $99 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Amgen | 2 | $96 |
| Sanofi | 1 | $96 |
| Neurelis, Inc. | 1 | $94 |
| Genentech, Inc. | 1 | $94 |
| Boehringer Ingelheim | 2 | $92 |
| Dexcom, Inc. | 2 | $62 |
| Novartis | 3 | $61 |
| Coloplast | 1 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Exact Sciences | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Merck | 2 | $33 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,396 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Tallahassee
- Kathleen WilsonTallahassee$154K
- Brittany YatesTallahassee$73K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.